-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Downgrades Apogee Therapeutics to Neutral

Benzinga·08/12/2026 10:29:51
Listen to the news
BTIG analyst Julian Harrison downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Neutral.